SFS 2013:790 Förordning om ändring i förordningen (1999:58) om förbud mot vissa hälsofarliga varor

130790.PDF

Källa Regeringskansliets rättsdatabaser m.fl.

<div><style type="text/css"> <!-- p {margin: 0; padding: 0;} .ft10{font-size:14px;font-family:IEKMAN+TimesNewRomanPS;color:#000000;} .ft11{font-size:27px;font-family:IEKMAO+TimesNewRomanPS;color:#000000;} .ft12{font-size:19px;font-family:IEKMAO+TimesNewRomanPS;color:#000000;} .ft13{font-size:8px;font-family:IEKMAN+TimesNewRomanPS;color:#000000;} .ft14{font-size:7px;font-family:IEKMAN+TimesNewRomanPS;color:#000000;} .ft15{font-size:12px;font-family:IEKMAN+TimesNewRomanPS;color:#000000;} .ft16{font-size:19px;line-height:19px;font-family:IEKMAO+TimesNewRomanPS;color:#000000;} .ft17{font-size:14px;line-height:17px;font-family:IEKMAN+TimesNewRomanPS;color:#000000;} .ft18{font-size:12px;line-height:14px;font-family:IEKMAN+TimesNewRomanPS;color:#000000;} .ft19{font-size:12px;line-height:12px;font-family:IEKMAN+TimesNewRomanPS;color:#000000;} .ft110{font-size:12px;line-height:15px;font-family:IEKMAN+TimesNewRomanPS;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft20{font-size:14px;font-family:IEKMAN+TimesNewRomanPS;color:#000000;} .ft21{font-size:15px;font-family:IEKMAO+TimesNewRomanPS;color:#000000;} .ft22{font-size:14px;font-family:IEKMDP+TimesNewRomanPS;color:#000000;} .ft23{font-size:8px;font-family:IEKMAN+TimesNewRomanPS;color:#000000;} .ft24{font-size:7px;font-family:IEKMAN+TimesNewRomanPS;color:#000000;} .ft25{font-size:12px;font-family:IEKMAN+TimesNewRomanPS;color:#000000;} .ft26{font-size:15px;line-height:17px;font-family:IEKMAO+TimesNewRomanPS;color:#000000;} .ft27{font-size:14px;line-height:17px;font-family:IEKMAN+TimesNewRomanPS;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft30{font-size:14px;font-family:IEKMAN+TimesNewRomanPS;color:#000000;} .ft31{font-size:15px;font-family:IEKMAO+TimesNewRomanPS;color:#000000;} .ft32{font-size:8px;font-family:IEKMAN+TimesNewRomanPS;color:#000000;} .ft33{font-size:14px;font-family:IEKMAO+TimesNewRomanPS;color:#000000;} .ft34{font-size:12px;font-family:IEKMAN+TimesNewRomanPS;color:#000000;} .ft35{font-size:14px;line-height:17px;font-family:IEKMAN+TimesNewRomanPS;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft40{font-size:8px;font-family:IEKMAN+TimesNewRomanPS;color:#000000;} --> </style> <div id="page1-div" style="position:relative;width:701px;height:1028px;"> <img width="701" height="1028" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:924px;left:646px;white-space:nowrap" class="ft10">1</p> <p style="position:absolute;top:80px;left:77px;white-space:nowrap" class="ft11"><b>Svensk f�rfattningssamling</b></p> <p style="position:absolute;top:187px;left:77px;white-space:nowrap" class="ft16"><b>F�rordning<br/>om �ndring i f�rordningen (1999:58) om f�rbud <br/>mot vissa h�lsofarliga varor;</b></p> <p style="position:absolute;top:263px;left:77px;white-space:nowrap" class="ft10">utf�rdad den 24 oktober 2013.</p> <p style="position:absolute;top:298px;left:91px;white-space:nowrap" class="ft10">Regeringen f�reskriver</p> <p style="position:absolute;top:296px;left:224px;white-space:nowrap" class="ft13">1 att bilagan till f�rordningen (1999:58) om f�rbud</p> <p style="position:absolute;top:315px;left:77px;white-space:nowrap" class="ft10">mot vissa h�lsofarliga varor ska ha f�ljande lydelse.</p> <p style="position:absolute;top:351px;left:91px;white-space:nowrap" class="ft10">Denna f�rordning tr�der i kraft den 1 december 2013.</p> <p style="position:absolute;top:386px;left:77px;white-space:nowrap" class="ft10">P� regeringens v�gnar</p> <p style="position:absolute;top:421px;left:77px;white-space:nowrap" class="ft10">G�RAN H�GGLUND</p> <p style="position:absolute;top:438px;left:307px;white-space:nowrap" class="ft17">Lars Hedengran<br/>(Socialdepartementet)</p> <p style="position:absolute;top:885px;left:77px;white-space:nowrap" class="ft19">1 Se Europaparlamentets och r�dets direktiv 98/34/EG av den 22 juni 1998 om ett in-<br/>formationsf�rfarande betr�ffande tekniska standarder och f�reskrifter (EGT L 204,<br/>21.7.1998, s. 37, Celex 31998L0034), �ndrat genom r�dets direktiv 98/48/EG (EGT L<br/>217, 5.8.1998, s. 18, Celex 31998L0048).</p> <p style="position:absolute;top:175px;left:536px;white-space:nowrap" class="ft12"><b>SFS 2013:790</b></p> <p style="position:absolute;top:202px;left:536px;white-space:nowrap" class="ft110">Utkom fr�n trycket<br/>den 5 november 2013</p> </div> <div id="page2-div" style="position:relative;width:701px;height:1028px;"> <img width="701" height="1028" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:924px;left:46px;white-space:nowrap" class="ft20">2</p> <p style="position:absolute;top:51px;left:46px;white-space:nowrap" class="ft21"><b>SFS 2013:790</b></p> <p style="position:absolute;top:51px;left:581px;white-space:nowrap" class="ft22"><i>Bilaga</i></p> <p style="position:absolute;top:49px;left:619px;white-space:nowrap" class="ft23">2</p> <p style="position:absolute;top:94px;left:181px;white-space:nowrap" class="ft26"><b>F�rteckning �ver varor som ska anses som h�lsofarliga varor <br/>enligt lagen om f�rbud mot vissa h�lsofarliga varor</b></p> <p style="position:absolute;top:141px;left:196px;white-space:nowrap" class="ft27">N-metyl-1-(3,4-metylendioxifenyl)-2-butylamin (MBDB)<br/>1-(3,4-metylendioxifenyl)-2-butylamin (BDB)<br/>5-metoxi-N,N-dimetyltryptamin (5-MeO-DMT)<br/>5-metoxi-N,N-diisopropyltryptamin (5-MeO-DIPT)<br/>5-metoxi-alfametyltryptamin (5-MeO-AMT)<br/>2,5-dimetoxi-4-etylfenetylamin (2C-E)<br/>alfa-metyltryptamin (AMT)<br/>2,5-dimetoxi-4-klorfenetylamin (2C-C)<br/>2,5-dimetoxi-4-metylfenetylamin (2C-D)<br/>4-acetoxi-N,N-diisopropyltryptamin (4-AcO-DIPT)<br/>4-hydroxi-N,N-diisopropyltryptamin (4-HO-DIPT)<br/>gammabutyrolakton (GBL)<br/>1,4-butandiol (1,4-BD)<br/>4-acetoxi-N,N-metylisopropyltryptamin (4-AcO-MIPT)<br/>4-hydroxi-N,N-metylisopropyltryptamin (4-HO-MIPT)<br/>4-acetoxi-N,N-dietyltryptamin (4-AcO-DET)<br/>4-hydroxi-N,N-dietyltryptamin (4-HO-DET)<br/>1-(3-trifluormetylfenyl)piperazin (TFMPP)<br/>2,5-dimetoxi-4-isopropyltiofenetylamin (2C-T-4)<br/>[2,3-dihydro-5-metyl-3-(4-morfolinylmetyl)pyrrolo[1,2,3-de]-1,4-bensox-</p> <p style="position:absolute;top:489px;left:181px;white-space:nowrap" class="ft20">azin-6-yl]-1-naftalenylmetanon (WIN 55,212-2)</p> <p style="position:absolute;top:506px;left:196px;white-space:nowrap" class="ft20">5-(1,1-dimetylheptyl)-2-[5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]fenol</p> <p style="position:absolute;top:524px;left:181px;white-space:nowrap" class="ft20">(CP 55,940)</p> <p style="position:absolute;top:541px;left:196px;white-space:nowrap" class="ft27">(2-metyl-1-pentylindol-3-yl)-(naftalen-1-yl)metanon (JWH-007)<br/>(2-metyl-1-propyl-1H-indol-3-yl)-1-naftalenylmetanon (JWH-015)<br/>(1-hexyl-1H-indol-3-yl)-1-naftalenylmetanon (JWH-019)<br/>2-metylnaftalen-1-yl-(butylindol-3-yl)metanon (JWH-073 metylderivat)<br/>4-metoxinaftalen-1-yl-(1-pentylindol-2-metyl-3-yl)metanon (JWH-098)<br/>1-hexyl-2-fenyl-4-(1-naftoyl)pyrrol (JWH-147)<br/>(4-metoxyfenyl)(1-pentyl-1H-indol-3-yl)metanon (RCS-4)<br/>2-(1H-indol-5-yl)-1-metyl-etylamin (5-IT)<br/>4-metylhexan-2-amin (DMAA)<br/>4-(2-aminopropyl)bensofuran (4-APB)<br/>5-(2-aminopropyl)bensofuran (5-APB)<br/>6-(2-aminopropyl)bensofuran (6-APB)<br/>(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetrametylcyclopropyl)metanon (UR-144)<br/>1-(1-bensofuran-5-yl)-N-metylpropan-2-amin (5-MAPB)<br/>1-(5-fluoropentyl)-N-tricyklo[3.3.1.1</p> <p style="position:absolute;top:783px;left:407px;white-space:nowrap" class="ft23">3,7]dek-1-yl-1H-indol-3-karboxamid</p> <p style="position:absolute;top:802px;left:181px;white-space:nowrap" class="ft20">(STS-135) </p> <p style="position:absolute;top:820px;left:196px;white-space:nowrap" class="ft20">1-pentyl-N-tricyklo[3.3.1.1</p> <p style="position:absolute;top:818px;left:351px;white-space:nowrap" class="ft23">3,7]dek-1-yl-1H-indol-3-karboxamid</p> <p style="position:absolute;top:837px;left:181px;white-space:nowrap" class="ft20">(APICA [JWH-018 adamantyl karboxamid])</p> <p style="position:absolute;top:854px;left:196px;white-space:nowrap" class="ft20">1-pentyl-N-tricyklo[3.3.1.1</p> <p style="position:absolute;top:853px;left:351px;white-space:nowrap" class="ft23">3,7]dek-1-yl-1H-indazol-3-karboxamid</p> <p style="position:absolute;top:872px;left:181px;white-space:nowrap" class="ft20">(AKB48)</p> <p style="position:absolute;top:921px;left:181px;white-space:nowrap" class="ft24">2 Senaste lydelse 2013:667.</p> </div> <div id="page3-div" style="position:relative;width:701px;height:1028px;"> <img width="701" height="1028" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:924px;left:649px;white-space:nowrap" class="ft30">3</p> <p style="position:absolute;top:51px;left:536px;white-space:nowrap" class="ft31"><b>SFS 2013:790</b></p> <p style="position:absolute;top:51px;left:91px;white-space:nowrap" class="ft30">(1-pentyl-1H-indol-3-yl)tricyklo[3.3.1.1</p> <p style="position:absolute;top:49px;left:320px;white-space:nowrap" class="ft32">3,7]dek-1-yl-metanon (AB-001)</p> <p style="position:absolute;top:68px;left:91px;white-space:nowrap" class="ft30">(1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetrametylcyklopropyl)met-</p> <p style="position:absolute;top:85px;left:77px;white-space:nowrap" class="ft30">anon (5F-UR-144<b>)</b></p> <p style="position:absolute;top:103px;left:91px;white-space:nowrap" class="ft35">1-(5-fluoropentyl)-1H-indol-3-karboxylsyra 8-kinolinester (5F-PB22)<br/>1-(5-fluoropentyl)-N-tricyklo[3.3.1.1</p> <p style="position:absolute;top:118px;left:303px;white-space:nowrap" class="ft32">3,7]dek-1-yl-1H-indazol-3-karbox-</p> <p style="position:absolute;top:138px;left:77px;white-space:nowrap" class="ft30">amid (5F-AKB48)</p> <p style="position:absolute;top:155px;left:91px;white-space:nowrap" class="ft30">1-[(5-kloropentyl)-1H-indol-3-yl]-(naftalen-1-yl)metanon (JWH-018 N-[5-</p> <p style="position:absolute;top:172px;left:77px;white-space:nowrap" class="ft30">kloropentyl] derivat)</p> <p style="position:absolute;top:190px;left:91px;white-space:nowrap" class="ft35">salvinorin A<br/>alla delar av v�xten Salvia divinorum fr�n vilka salvinorin A inte blivit</p> <p style="position:absolute;top:225px;left:77px;white-space:nowrap" class="ft30">extraherat och oavsett under vilka ben�mningar de f�rekommer</p> <p style="position:absolute;top:254px;left:91px;white-space:nowrap" class="ft30">Salter av �mnena n�r s�dana kan f�rekomma.</p> </div> <div id="page4-div" style="position:relative;width:701px;height:1028px;"> <img width="701" height="1028" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:946px;left:529px;white-space:nowrap" class="ft40">Norstedts Juridik AB/Fritzes</p> <p style="position:absolute;top:956px;left:534px;white-space:nowrap" class="ft40">Elanders Sverige AB, 2013</p> </div> </div>
background image

1

Svensk f�rfattningssamling

F�rordning
om �ndring i f�rordningen (1999:58) om f�rbud
mot vissa h�lsofarliga varor;

utf�rdad den 24 oktober 2013.

Regeringen f�reskriver

1 att bilagan till f�rordningen (1999:58) om f�rbud

mot vissa h�lsofarliga varor ska ha f�ljande lydelse.

Denna f�rordning tr�der i kraft den 1 december 2013.

P� regeringens v�gnar

G�RAN H�GGLUND

Lars Hedengran
(Socialdepartementet)

1 Se Europaparlamentets och r�dets direktiv 98/34/EG av den 22 juni 1998 om ett in-
formationsf�rfarande betr�ffande tekniska standarder och f�reskrifter (EGT L 204,
21.7.1998, s. 37, Celex 31998L0034), �ndrat genom r�dets direktiv 98/48/EG (EGT L
217, 5.8.1998, s. 18, Celex 31998L0048).

SFS 2013:790

Utkom fr�n trycket
den 5 november 2013

background image

2

SFS 2013:790

Bilaga

2

F�rteckning �ver varor som ska anses som h�lsofarliga varor
enligt lagen om f�rbud mot vissa h�lsofarliga varor

N-metyl-1-(3,4-metylendioxifenyl)-2-butylamin (MBDB)
1-(3,4-metylendioxifenyl)-2-butylamin (BDB)
5-metoxi-N,N-dimetyltryptamin (5-MeO-DMT)
5-metoxi-N,N-diisopropyltryptamin (5-MeO-DIPT)
5-metoxi-alfametyltryptamin (5-MeO-AMT)
2,5-dimetoxi-4-etylfenetylamin (2C-E)
alfa-metyltryptamin (AMT)
2,5-dimetoxi-4-klorfenetylamin (2C-C)
2,5-dimetoxi-4-metylfenetylamin (2C-D)
4-acetoxi-N,N-diisopropyltryptamin (4-AcO-DIPT)
4-hydroxi-N,N-diisopropyltryptamin (4-HO-DIPT)
gammabutyrolakton (GBL)
1,4-butandiol (1,4-BD)
4-acetoxi-N,N-metylisopropyltryptamin (4-AcO-MIPT)
4-hydroxi-N,N-metylisopropyltryptamin (4-HO-MIPT)
4-acetoxi-N,N-dietyltryptamin (4-AcO-DET)
4-hydroxi-N,N-dietyltryptamin (4-HO-DET)
1-(3-trifluormetylfenyl)piperazin (TFMPP)
2,5-dimetoxi-4-isopropyltiofenetylamin (2C-T-4)
[2,3-dihydro-5-metyl-3-(4-morfolinylmetyl)pyrrolo[1,2,3-de]-1,4-bensox-

azin-6-yl]-1-naftalenylmetanon (WIN 55,212-2)

5-(1,1-dimetylheptyl)-2-[5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]fenol

(CP 55,940)

(2-metyl-1-pentylindol-3-yl)-(naftalen-1-yl)metanon (JWH-007)
(2-metyl-1-propyl-1H-indol-3-yl)-1-naftalenylmetanon (JWH-015)
(1-hexyl-1H-indol-3-yl)-1-naftalenylmetanon (JWH-019)
2-metylnaftalen-1-yl-(butylindol-3-yl)metanon (JWH-073 metylderivat)
4-metoxinaftalen-1-yl-(1-pentylindol-2-metyl-3-yl)metanon (JWH-098)
1-hexyl-2-fenyl-4-(1-naftoyl)pyrrol (JWH-147)
(4-metoxyfenyl)(1-pentyl-1H-indol-3-yl)metanon (RCS-4)
2-(1H-indol-5-yl)-1-metyl-etylamin (5-IT)
4-metylhexan-2-amin (DMAA)
4-(2-aminopropyl)bensofuran (4-APB)
5-(2-aminopropyl)bensofuran (5-APB)
6-(2-aminopropyl)bensofuran (6-APB)
(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetrametylcyclopropyl)metanon (UR-144)
1-(1-bensofuran-5-yl)-N-metylpropan-2-amin (5-MAPB)
1-(5-fluoropentyl)-N-tricyklo[3.3.1.1

3,7]dek-1-yl-1H-indol-3-karboxamid

(STS-135)

1-pentyl-N-tricyklo[3.3.1.1

3,7]dek-1-yl-1H-indol-3-karboxamid

(APICA [JWH-018 adamantyl karboxamid])

1-pentyl-N-tricyklo[3.3.1.1

3,7]dek-1-yl-1H-indazol-3-karboxamid

(AKB48)

2 Senaste lydelse 2013:667.

background image

3

SFS 2013:790

(1-pentyl-1H-indol-3-yl)tricyklo[3.3.1.1

3,7]dek-1-yl-metanon (AB-001)

(1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetrametylcyklopropyl)met-

anon (5F-UR-144)

1-(5-fluoropentyl)-1H-indol-3-karboxylsyra 8-kinolinester (5F-PB22)
1-(5-fluoropentyl)-N-tricyklo[3.3.1.1

3,7]dek-1-yl-1H-indazol-3-karbox-

amid (5F-AKB48)

1-[(5-kloropentyl)-1H-indol-3-yl]-(naftalen-1-yl)metanon (JWH-018 N-[5-

kloropentyl] derivat)

salvinorin A
alla delar av v�xten Salvia divinorum fr�n vilka salvinorin A inte blivit

extraherat och oavsett under vilka ben�mningar de f�rekommer

Salter av �mnena n�r s�dana kan f�rekomma.

background image

Norstedts Juridik AB/Fritzes

Elanders Sverige AB, 2013

;